Related Experiment Video
Updated: Nov 19, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Over 10-Year Outcomes of Infantile-Onset Epilepsies
Hyun-Jin Kim1, Han Na Jang2, Hyunji Ahn2
1Department of Pediatrics, Myongji Hospital, Goyang 10475, Korea.
Insights
Infantile-onset epilepsy often shows variable outcomes, with many experiencing remission. However, some cases involve intractable seizures and developmental issues, highlighting the need for timely diagnosis and treatment.
Area of Science:
- Pediatric Neurology
- Epileptology
- Clinical Neuroscience
Background:
- Infantile-onset epilepsy presents diverse clinical courses and etiologies.
- Long-term follow-up studies on infantile epilepsy are limited.
- Understanding long-term outcomes is crucial for management.
Purpose of the Study:
- To analyze clinical courses and seizure outcomes of infantile-onset epilepsy.
- To identify risk factors associated with intractable epilepsy.
- To provide insights from a decade-long follow-up in a tertiary center.
Main Methods:
- Retrospective review of electronic medical records.
- Inclusion criteria: epilepsy diagnosed before 12 months, >10 years follow-up.
- Outcome assessment based on seizure freedom duration.
Main Results:
- 146 patients analyzed; 70.5% achieved remission.
- Epilepsy resolved in 31.5%; 33.6% had intractable epilepsy.
- Delayed development, neurological deficits, and later onset (>3 months) linked to intractable cases (p < 0.01).
Conclusions:
- Many infantile-onset epilepsy cases achieve seizure remission.
- Early-onset epilepsy can be associated with comorbidities and intractable seizures.
- Prompt diagnosis and treatment are vital to prevent neuropsychiatric complications.
Abstract:
Seizures in infancy have highly variable courses and underlying etiologies. However, there are only a few long-term follow-up studies regarding infantile-onset epilepsy. Therefore, we aimed to describe the clinical courses, seizure outcomes, and risk factors of infantile-onset epilepsy followed up for more than 10 years in a tertiary center.
Methods:
Data of the patients with epilepsy, diagnosed under the age of 12 months and followed up for more than 10 years, were retrieved from the electronic medical records of Asan Medical Center Children's Hospital. The patients' medical records were retrospectively reviewed, and clinical outcomes were assessed based on the duration of seizure freedom at the last follow-up.
Results:
Of the 146 patients, 103 (70.5%) entered at least one remission, of whom epilepsy was resolved in 46 (31.5%). Forty-nine (33.6%) were found to be intractable at last contact. Delayed development, neurological deficits, and later onset (>3 months) were significantly associated with intractable epilepsies (p < 0.01).
Conclusions:
This study demonstrated that many patients with infantile-onset epilepsy can experience seizure remission. However, in some cases, early onset epilepsy was highly associated with various comorbidities and intractable seizures. Therefore, appropriate diagnosis and treatment are necessary to prevent further neuropsychiatric complications.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Long-term Potentiation
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

